Overview
Yu Liu practices in Chengdu, China. Liu is rated as an Advanced expert by MediFind in the treatment of Small Cell Lung Cancer (SCLC). Their top areas of expertise are Small Cell Lung Cancer (SCLC), Esophageal Cancer, Angioimmunoblastic T-cell Lymphoma, and Lymphofollicular Hyperplasia.
Their clinical research consists of co-authoring 22 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 4 articles in the study of Small Cell Lung Cancer (SCLC).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Small Cell Lung Cancer (SCLC)
- Experienced
- Angioimmunoblastic T-cell Lymphoma
- Esophageal CancerLiu isExperienced. Learn about Esophageal Cancer.
- Lung CancerLiu isExperienced. Learn about Lung Cancer.
- Lymphofollicular Hyperplasia
- Non-Hodgkin LymphomaLiu isExperienced. Learn about Non-Hodgkin Lymphoma.
- T-Cell LymphomaLiu isExperienced. Learn about T-Cell Lymphoma.